文献速递临床试验与 GCP

远端胰腺切除术中隔离手术与常规手术对比(ISOP-DP试验):随机对照试验研究方案

ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-09-16

ISOP-DP试验为多中心随机对照试验,计划纳入100例拟行远端胰腺脾切除术的胰腺导管腺癌患者,术前随机分为常规手术组(A组)或隔离手术组(B组)。主要终点为意向性治疗分析下的2年无复发生存率,次要终点包括术中出血量、R0切除率和总生存期。

要点

  • 隔离手术组先离断脾动脉根部、横断胰腺、再离断脾静脉,常规组先游离后切除淋巴结。
  • 主要终点为意向性治疗分析下的2年无复发生存率。
  • 次要终点包括术中出血量、R0切除率和总生存期。

核心结论

  • 若隔离手术能提高生存且R0切除率和淋巴结清扫数目与常规手术相当,有望成为远端胰腺脾切除术治疗胰腺导管腺癌的标准术式。
  • 若两组终点无显著差异,则从外科和肿瘤学角度可证明两种术式均合理。

研究设计与样本

  • 多中心随机对照试验,计划纳入100例来自日本高容量中心的胰腺导管腺癌患者。
  • 患者术前随机分为常规手术组(A组)或隔离手术组(B组)。

主要发现

  • 原文为研究方案,未报告试验结果。
  • 背景提及在胰腺导管腺癌中,隔离手术已被显示可减少术中出血量并通过完整清扫淋巴结提高R0切除率。

关键数值与推荐

  • 主要终点:意向性治疗分析下的2年无复发生存率。
  • 次要终点包括术中出血量、R0切除率和总生存期。
  • A组:游离胰体尾及脾后切除区域淋巴结,脾静脉在手术结束时离断,脾动脉离断时机不限。
  • B组:先清扫区域淋巴结,然后依次离断脾动脉根部、横断胰腺、离断脾静脉,最后游离并切除胰体尾及脾。
  • 试验注册号:UMIN000041381(2020年8月10日注册)、NCT04600063(2020年10月22日注册)。

临床怎么用

  • 该试验旨在比较隔离手术与常规手术在远端胰腺脾切除术治疗胰腺导管腺癌中的生存获益。
  • 若结果阳性,隔离手术可能成为标准术式;若阴性,则两种术式均可接受。

局限性

  • 原文未报告试验结果,仅为研究方案。
  • 样本量100例,来自日本高容量中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radical antegrade modular pancreatosplenectomy (RAMPS) is an isolation procedure in pancreatosplenectomy for pancreatic body/tail cancer. Connective tissues around the bifurcation of the celiac axis are dissected, followed by median-to-left retroperitoneal dissection. This procedure has the potential to isolate blood and lymphatic flow to the area of the pancreatic body/tail and the spleen to be excised. This is achieved by division of the inflow artery, transection of the pancreas, and then division of the outflow vein in the early phases of surgery. In cases of pancreatic ductal adenocarcinoma (PDAC), the procedure has been shown to decrease intraoperative blood loss and increase R0 resection rate by complete clearance of the lymph nodes. This trial investigates whether the isolation procedure can prolong the survival of patients with pancreatic ductal adenocarcinoma who undergo distal pancreatosplenectomy (DPS) compared with those that undergo the conventional approach. METHODS/DESIGN: Patients with PDAC scheduled to undergo DPS are randomized before surgery to undergo either a conventional procedure (arm A) or to undergo the isolation procedure (arm B). In arm A, the pancreatic body, tail, and spleen are mobilized, followed by removal of the regional lymph nodes. The splenic vein is transected at the end of the procedure. The timing of division of the splenic artery (SA) is not restricted. In arm B, regional lymph nodes are dissected, then we transect the root of the SA, the pancreas, then the splenic vein. At the end of the procedure, the pancreatic body/tail and spleen are mobilized and removed. In total, 100 patients from multiple Japanese high-volume centers will be randomized. The primary endpoint is 2-year recurrence-free survival by intention-to-treat analysis. Secondary endpoints include intraoperative blood loss, R0 resection rate, and overall survival. DISCUSSION: If this trial shows that the isolation procedures can improve survival with a similar R0 rate and with a similar number of lymph node dissections to the conventional procedure, the isolation procedure is expected to become a standard procedure during DPS for PDAC. Conversely, if there were no significant differences in endpoints between the groups, it would demonstrate justification of either procedure from surgical and oncological points of view. TRIAL REGISTRATION: UMIN Clinical Trials Registry UMIN000041381 . Registered on 10 August 2020. ClinicalTrials.gov NCT04600063 . Registered on 22 October 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Okada KI, Kawai M, Hirono S, et al. ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial. Trials. 2021. PMID: 34530885. doi:10.1186/s13063-021-05523-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。